| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
96.28(B) |
| Last
Volume: |
6,966,277 |
Avg
Vol: |
8,465,245 |
| 52
Week Range: |
$48.64 - $68.84 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
86,763 |
367,796 |
891,893 |
1,852,495 |
| Total Sell Value |
$5,815,387 |
$21,391,604 |
$49,075,093 |
$90,475,166 |
| Total People Sold |
6 |
8 |
11 |
13 |
| Total Sell Transactions |
9 |
19 |
36 |
69 |
| End Date |
2024-01-21 |
2023-10-20 |
2023-04-21 |
2022-04-21 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
• • – |
2013-05-31 |
4 |
S |
$9.36 |
$102,467 |
D/D |
(10,941) |
62,957 |
|
- |
|
| Carruthers Wendy |
SVP, Human Resources |
• • – |
2013-05-30 |
4 |
S |
$9.14 |
$228,939 |
D/D |
(25,001) |
19,158 |
|
- |
|
| Connors Nelda J |
Director |
• • – |
2013-05-29 |
4 |
S |
$9.17 |
$221,144 |
D/D |
(24,116) |
0 |
|
- |
|
| Capello Jeffrey D |
EVP & Chief Financial Officer |
• • – |
2013-05-12 |
4 |
D |
$8.45 |
$19,934 |
D/D |
(2,359) |
189,089 |
|
- |
|
| Capello Jeffrey D |
EVP & Chief Financial Officer |
• • – |
2013-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,235 |
191,448 |
|
- |
|
| Byrnes Bruce L |
Director |
• • – |
2013-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
22,756 |
98,920 |
|
- |
|
| Reinhardt Uwe E |
Director |
• • – |
2013-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
22,756 |
146,202 |
|
- |
|
| Nicholas Peter M |
Director |
• • – |
2013-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
22,756 |
3,437,495 |
|
- |
|
| Bartlett Katharine T |
Director |
• • – |
2013-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
22,756 |
52,464 |
|
- |
|
| Mario Ernest |
Director |
• • – |
2013-05-06 |
4 |
B |
$7.76 |
$232,800 |
D/D |
30,000 |
509,304 |
2.39 |
- |
|
| Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
• • – |
2013-05-01 |
4 |
D |
$7.49 |
$36,012 |
D/D |
(4,808) |
139,143 |
|
- |
|
| Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
• • – |
2013-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,746 |
143,951 |
|
- |
|
| Capello Jeffrey D |
EVP & Chief Financial Officer |
• • – |
2013-02-28 |
4 |
D |
$7.39 |
$25,237 |
D/D |
(3,415) |
184,213 |
|
- |
|
| Capello Jeffrey D |
EVP & Chief Financial Officer |
• • – |
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,474 |
187,628 |
|
- |
|
| Carruthers Wendy |
SVP, Human Resources |
• • – |
2013-02-28 |
4 |
D |
$7.39 |
$6,732 |
D/D |
(911) |
44,159 |
|
- |
|
| Carruthers Wendy |
SVP, Human Resources |
• • – |
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,793 |
45,070 |
|
- |
|
| Ballinger Kevin J. |
SVP & Pres, Interven Cardio |
• • – |
2013-02-28 |
4 |
D |
$7.39 |
$13,871 |
D/D |
(1,877) |
111,690 |
|
- |
|
| Ballinger Kevin J. |
SVP & Pres, Interven Cardio |
• • – |
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,586 |
113,567 |
|
- |
|
| Dawkins Keith D |
EVP, Global Chief Med. Off. |
• • – |
2013-02-28 |
4 |
D |
$7.39 |
$11,780 |
D/D |
(1,594) |
81,802 |
|
- |
|
| Dawkins Keith D |
EVP, Global Chief Med. Off. |
• • – |
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,888 |
83,396 |
|
- |
|
| Fitzgerald Joseph Michael |
SVP & President, CRM |
• • – |
2013-02-28 |
4 |
D |
$7.39 |
$8,668 |
D/D |
(1,173) |
93,724 |
|
- |
|
| Fitzgerald Joseph Michael |
SVP & President, CRM |
• • – |
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,491 |
94,897 |
|
- |
|
| Nanavaty Maulik |
SVP & Pres, Neuromodulation |
• • – |
2013-02-28 |
4 |
D |
$7.39 |
$6,156 |
D/D |
(833) |
76,288 |
|
- |
|
| Nanavaty Maulik |
SVP & Pres, Neuromodulation |
• • – |
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,269 |
77,121 |
|
- |
|
| Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
• • – |
2013-02-28 |
4 |
D |
$7.39 |
$25,237 |
D/D |
(3,415) |
129,205 |
|
- |
|
1851 Records found
|
|
Page 9 of 75 |
|
|
0.09 (0.13%) 
